Drugs that contain Ospemifene

1. List of Osphena drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9566252 DUCHESNAY Method for the alleviation of dyspareunia in women
Nov, 2022

(3 months ago)

US8470890 DUCHESNAY Method for enhancing the bioavailability of ospemifene
Feb, 2024

(1 year, 3 days from now)

US8772353 DUCHESNAY Method for enhancing the bioavalability of ospemifene
Feb, 2024

(1 year, 3 days from now)

US9855224 DUCHESNAY Method for enhancing the bioavailability of ospemifene
Feb, 2024

(1 year, 3 days from now)

US9241915 DUCHESNAY Method for enhancing the bioavailability of ospemifene
Feb, 2024

(1 year, 3 days from now)

US6245819 DUCHESNAY Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
Jul, 2025

(2 years from now)

US8236861 DUCHESNAY Method for enhancing the bioavailablity of ospemifene
Aug, 2026

(3 years from now)

US8642079 DUCHESNAY Solid formulations of ospemifene
Jul, 2028

(5 years from now)

Exclusivity Exclusivity Expiration
New Indication (I) Jan 25, 2022

Market Authorisation Date: 26 February, 2013

Treatment: Treatment of dyspareunia associated with menopause; Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause; Treatment of vaginal symptoms of urogenital atrophy by orally administering ospemifene with food to enhance bioavailability of ospemifene

Dosage: TABLET;ORAL

How can I launch a generic of OSPHENA before it's patent expiration?
More Information on Dosage

OSPHENA family patents

12

United States

5

Japan

4

Australia

4

Russia

4

Norway

4

European Union

3

Austria

3

Brazil

3

Finland

3

Poland

3

Spain

3

Germany

3

Mexico

3

Slovenia

3

Portugal

3

China

3

Canada

3

Denmark

2

Cyprus

2

Hungary

1

Estonia

1

Hong Kong

1

Korea, Republic of

1

Lithuania

1

Ukraine

1

Luxembourg

1

Slovakia

1

Israel

1

South Africa

1

Bulgaria

1

Croatia

1

New Zealand

1

Czech Republic

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic